Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

被引：38

作者：

Beal, Eliza W. ^{[1
,2
]}

Ahmed, Ahmed ^{[1
,2
]}

Grotz, Travis ^{[3
]}

Leiting, Jennifer ^{[3
]}

Fournier, Keith F. ^{[4
]}

Lee, Andrew J. ^{[4
]}

Dineen, Sean ^{[5
]}

Dessureault, Sophie ^{[5
]}

Baumgartner, Joel M. ^{[6
]}

Veerapong, Jula ^{[6
]}

Clarke, Callisia ^{[7
]}

Strong, Erin ^{[7
]}

Maithel, Shishir K. ^{[8
]}

Zaidi, Mohammad Y. ^{[8
]}

Patel, Sameer ^{[9
]}

Dhar, Vikrom ^{[9
]}

Hendrix, Ryan ^{[10
]}

Lambert, Laura ^{[10
]}

Johnston, Fabian ^{[11
]}

Fackche, Nadege ^{[11
]}

Raoof, Mustafa ^{[12
]}

LaRocca, Christopher ^{[12
]}

Ronnekleiv-Kelly, Sean ^{[13
]}

Pokrzywa, Courtney ^{[13
]}

Pawlik, Timothy M. ^{[1
,2
]}

Abdel-Misih, Sherif ^{[1
,2
]}

Cloyd, Jordan M. ^{[1
,2
]}

机构：

[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA

[2] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA

[3] Mayo Clin, Rochester, MN USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Univ Calif San Diego, San Diego, CA 92103 USA

[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[8] Emory Univ, Atlanta, GA 30322 USA

[9] Univ Cincinnati, Cincinnati, OH USA

[10] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA

[11] Johns Hopkins Univ, Baltimore, MD USA

[12] City Hope Natl Med Ctr, Duarte, CA USA

[13] Univ Wisconsin, Madison, WI USA

来源：

AMERICAN JOURNAL OF SURGERY | 2020年 / 219卷 / 03期

关键词：

Cytoreductive surgery; Hyperthermic intraperitoneal; chemotherapy; CRS; HIPEC;

D O I：

10.1016/j.amjsurg.2019.09.017

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an increasingly utilized strategy for patients with peritoneal surface malignancies (PSM). Methods: The US HIPEC Collaborative was retrospectively reviewed to compare the indications and perioperative outcomes of patients who underwent CRS +/- HIPEC between 2000 and 2012 (P1) versus 2013-2017 (P2). Results: Among 2,364 patients, 39% were from P1 and 61% from P2. The most common primary site was appendiceal (64%) while the median PCI was 13 and most patients had CCR 0 (60%) or 1 (25%). Over time, median estimated blood loss, need for transfusion, and length of hospital stay decreased. While the incidence of any (55% vs. 57%; p = 0.426) and Clavien III/IV complications did not change over time, there was a decrease in 90-day mortality (5% vs. 3%; p = 0.045). Conclusion: CRS-HIPEC is increasingly performed for PSM at high-volume centers. Despite improvements in some perioperative outcomes and a reduction in postoperative mortality, morbidity rates remain high. (C) 2019 Elsevier Inc. All rights reserved.

引用

页码：478 / 483

页数：6

共 50 条

[1] Discussion on: Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
不详
[J]. AMERICAN JOURNAL OF SURGERY, 2020, 219 (03): : 484 - 485
[2] Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Gani, Faiz
Conca-Cheng, Alison M.
Nettles, Brenda
Ahuja, Nita
Johnston, Fabian M.
[J]. JOURNAL OF SURGICAL RESEARCH, 2019, 234 : 240 - 248
[3] Short-term Quality of Life after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Duzgun, Ozgul
Sarici, Inanc Samil
Gokcay, Serkan
[J]. ISTANBUL MEDICAL JOURNAL, 2018, 19 (02): : 143 - 146
[4] Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes
Mogal, Harveshp
Chouliaras, Konstantinos
Levine, Edward A.
Shen, Perry
Votanopoulos, Konstantinos I.
[J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (01) : 129 - 142
[5] Association of anesthesia handovers with perioperative and short-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Radomski, Shannon N.
Kajstura, Tymoteusz
Florissi, Isabella S.
Winicki, Nolan M.
Zeng, Yong
Jennings, Jacky M.
Johnston, Fabian M.
Berman, David J.
Greer, Jonathan B.
[J]. SURGERY, 2024, 176 (05) : 1450 - 1457
[6] Short-term Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Preliminary Analysis of a Multicentre Study
Macri, Antonio
Arcoraci, Vincenzo
Belgrano, Valerio
Caldana, Marina
Cioppa, Tommaso
Costantini, Barbara
Cucinotta, Eugenio
De Cian, Franco
De Iaco, Pierandrea
De Manzoni, Giovanni
Di Giorgio, Angelo
Fleres, Francesco
Muffatti, Francesca
Orsenigo, Elena
Pinna, Antonio Daniele
Roviello, Franco
Sammartino, Paolo
Scambia, Giovanni
Saladino, Edoardo
[J]. ANTICANCER RESEARCH, 2014, 34 (10) : 5689 - 5693
[7] Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review
Auer, Rebecca C.
Sivajohanathan, Duvaraga
Biagi, Jim
Conner, James
Kennedy, Erin
May, Taymaa
[J]. EUROPEAN JOURNAL OF CANCER, 2020, 127 : 76 - 95
[8] Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly
Tabrizian, Parissa
Jibara, Ghalib
Shrager, Brian
Franssen, Bernardo
Yang, Ming-Jim
Sarpel, Umut
Hiotis, Spiros
Labow, Daniel
[J]. SURGICAL ONCOLOGY-OXFORD, 2013, 22 (03): : 184 - 189
[9] Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline
Auer, R. C.
Sivajohanathan, D.
Biagi, J.
Conner, J.
Kennedy, E.
May, T.
[J]. CURRENT ONCOLOGY, 2020, 27 (03) : 146 - 154
[10] Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part I: Introduction and Indications
Dunn, Debra
[J]. AORN JOURNAL, 2019, 110 (05) : 479 - 496

← 1 2 3 4 5 →